Grifols Stock Discussion

$Grifols (GRFS.US)$ Investing.com -- Shares of Grifols SA (BME:GRLS) (NASDAQ:GRFS) rose on Wednesday after Bloomberg News reported that Brookfield Asset Management (TSX:BAM) is seeking bank backing for up to €9.5 billion in debt to facilitate its potential take-private acquisition of the Spanish pharmaceutical producer

$Grifols (GRFS.US)$ Benzinga· 2 mins ago
FDA Approves Expanded Label For Grifols' XEMBIFY, The First 20% SCIg For Treatment-Naïve Patients With Primary Humoral Immunodeficiencies; Approval Includes Biweekly Dosing Following Positive Phase 4 Data, Enhancing Flexibility And Convenience For Patients

Morning traders, it is the final slow week before a new earnings season begins Thurday with   $Delta Air Lines (DAL.US)$ and properly on Friday with   $JPMorgan (JPM.US)$.
Welcome to the end of the dog days of summer for a while; my name is Kevin Travers, and here are stories from the moomoo herd on Wall Street today.
$Intel (INTC.US)$ traded higher after the firm said it had bypassed Vietnam for a $3.3B project and in...

$Grifols (GRFS.US)$ PM high broke

1. $Shapeways (SHPW.US)$
2. $Inspire Veterinary Partners (IVP.US)$
3. $Dynatronics (DYNT.US)$
4. $Zapp Electric Vehicles (ZAPP.US)$
5. $Maxeon Solar Technologies (MAXN.US)$
6. $Grifols (GRFS.US)$
7. $SinglePoint (SING.US)$
8. $Venus Concept (VERO.US)$
9. $IDEAYA Biosciences (IDYA.US)$
10. $Kuke Music (KUKE.US)$

$Grifols (GRFS.US)$ Grifols' founding family and Canadian fund Brookfield are considering a joint takeover bid of the Spanish drugmaker to take it private, after the company shed billions in market value following a variety of accusations from a short-seller.

$Grifols (GRFS.US)$ Grifols Says €1.6 Billion Net Cash Proceeds From Sale Of 20% Equity Stake In Shanghai RAAS Are Currently Deposited In Co's Bank Account; Proceeds Will Be Fully Allocated To Reduce 2025 Senior Secured Notes And 2027 Term Loan B And On A Pro-Rata Basis As Per Credit Agreement; To Repay In Full 2025 Debt Maturities, Leaving No Additional Maturities Until 2027
- Reuters

$Grifols (GRFS.US)$ Grifols' Subsidiary Biotest Receives FDA Approval For Yimmugo, An Intravenous Immunoglobulin Therapeutic, To Treat Primary Immunodeficiencies, With US Launch Expected In Second Part Of 2024
Benzinga· 1 min ago

$Grifols (GRFS.US)$ Notorious Short seller GOTHAM spread FUD and crashes price a few weeks back! And then others keep posting the hit piece! But you hardly see any stories that GRIFOLS has filed a lawsuit against GOTHAM for that accusation! Grrrr! Well here GOTHAM, take this! Not great but good start! At least IMO!                                                                (((((((((.   Grifols Q1 Net Revenues €1.63 Billion Vs €1.56 Billion YoY; Sees Q1 R&D Negative Net Investment €90.5 M...

$Grifols (GRFS.US)$ MT Newswires· 3 mins ago
Grifols (GRF.MC) said Monday that the sale of its 20% stake in blood products company Shanghai RAAS to Chinese home appliance company Haier Group is expected to be completed by June.
The Spanish pharmaceutical company said both the buyer and seller secured the necessary domestic and overseas government approvals for the deal. It noted that the transaction still requires a compliance confirmation from the Shenzhen Stock Exchange.